The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which she experienced when taking opioids.
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...
Ontario’s associate minister of mental health and addictions says the best way to curb the number of people entering the ...
But all of those promises have turned out to be overstated or simply wrong. Legalization has raised cannabis consumption ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.